[COVI] MEP Sinčić vs. Sanofi: Was the initial study manipulated for marketing reasons?

Exchange of views with Thomas Triomphe, Executive Vice-President of
Vaccines, Sanofi

[COVI] Special Committee on the COVID-19 pandemic: lessons learned and recommendations for the future
Monday, 5 September 2022

// The sole liability for the opinions stated rests with the author. These opinions do not necessarily reflect the opinions of the European Parliament. //

https://www.facebook.com/ivsincic​​
https://ivsincic.eu/objave/category/video/